Search
Forian Inc
FORAAdd to Watchlist
2.170USD
0.0000.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
64.01MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+0.93%
1 Month
+0.46%
6 Months
+1.40%
Year to Date
+2.36%
1 Year
+0.93%
TradingKey Stock Score of Forian Inc
Currency: USD Updated: 2026-05-14Key Insights
Forian Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 186 out of 470 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 2.10.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Forian Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Forian Inc Highlights
StrengthsRisks
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 42.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 30.26M.
Fairly Valued
The company’s latest PE is -23.49, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.40M shares, increasing 8.00% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 56.00K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.21.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
2.100
Target Price
-3.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Forian Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Forian Inc Info
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
Ticker SymbolFORA
CompanyForian Inc
CEOWygod (Max)
Websitehttps://forian.com/
Related Instruments
-1.07%
-0.97%
+3.05%
-0.68%
+1.02%
-1.34%
+0.92%
+0.09%
+0.19%
-6.05%
+0.47%
+3.28%
+1.94%
+3.26%
+0.58%
+2.44%
+3.56%
+0.26%
+2.94%
+2.95%Popular Instruments
102.160
+3.297 (+3.33%)
300.230
+2.020 (+0.68%)
225.320
-10.420 (-4.42%)
4538.710
-111.520 (-2.40%)
482.020
-7.101 (-1.45%)
1407.610
+24.890 (+1.80%)
724.660
-51.350 (-6.62%)
396.780
-4.290 (-1.07%)
78113.430
-117.570 (-0.15%)
422.240
-21.060 (-4.75%)
